Showing results (251-260 of 419) with videos related to
Sort By:
Pageof 42
Journal of Extracellular Vesicles|February 22, 2021
Proteomic profile of melanoma cell-derived small extracellular vesicles in patients' plasma: a potential correlate of melanoma progressionMonika Pietrowska, Aneta Zebrowska, Marta Gawin, et al.Journal of Experimental & Clinical Cancer Research : CR|August 23, 2025
B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancerGiulia Cattaneo, Marco Ventin, Shahrzad Arya, et al.Molecular Cancer|March 17, 2025
IL-4 mediated TAP2 downregulation is a dominant and reversible mechanism of immune evasion and immunotherapy resistance in non-small cell lung cancerKishu Ranjan, Barani Kumar Rajendran, Imad Ud Deen, et al.Pigment Cell & Melanoma Research|October 19, 2011
CSPG4, a potential therapeutic target, facilitates malignant progression of melanomaMatthew A Price, Leah E Colvin Wanshura, Jianbo Yang, et al.Journal for Immunotherapy of Cancer|March 12, 2022
Differential role of HLA-A and HLA-B, C expression levels as prognostic markers in colon and rectal cancerTheodoros Michelakos, Filippos Kontos, Tomohiro Kurokawa, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2021
Spatial Analysis and Clinical Significance of HLA Class-I and Class-II Subunit Expression in Non-Small Cell Lung CancerIla J Datar, Sacha C Hauc, Shruti Desai, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2013
LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastomaJacky T Yeung, Ronald L Hamilton, Koji Ohnishi, et al.Cancer Immunology, Immunotherapy : CII|August 5, 2008
Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodiesAllison S Drake, Michael T Brady, Xin Hui Wang, et al.Frontiers in Immunology|May 13, 2017
FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical RelevanceSara Caratelli, Tommaso Sconocchia, Roberto Arriga, et al.BMC Cancer|February 24, 2007
HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expressionJan Willem F Dierssen, Noel F C C de Miranda, Soldano Ferrone, et al.Pageof 42